The US Food and Drug Administration (FDA) has published a report entitled Drug Shortages: Root Causes and Potential Solutions.
This report was commissioned following a request from Congress last year in response to shortages in the USA, and involved a team of FDA economists and scientists analyzing drugs that went into shortage from 2013 to 2017.
The FDA also sought input from industry, academics and other actors to gain further insights into the issue.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze